EPIRUBICINOL Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Dark Red Solid

Verwenden

A metabolite of Epirubicin, a neoplasm inhibitor.

EPIRUBICINOL Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

EPIRUBICINOL Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd	+8618791163155	18791163155@163.com	China	3397	58
J & K SCIENTIFIC LTD.	18210857532; 18210857532	jkinfo@jkchemical.com	China	96815	76
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32321	50
Cato Research Chemicals Inc.	020-81960175	min.he@cato-chem.com	China	1955	55
Hubei Yangxin Medical Technology Co., Ltd.	15374522761	3003392093@yongstandards.com	China	9929	55
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 +86-13028896684;	sales@rrkchem.com	China	57422	58
Energy Chemical	021-58432009 400-005-6266	marketing@energy-chemical.com	China	44918	58
ShenZhen H&D Pharmaceutical Technology Co., LTD	13986652530	zhangweiyue@hdimpurity.com	China	7902	58
Santa Cruz Biotechnology Inc	--	scbt@scbt.com	China	6594	58
TargetMol	400-821-0310 15002144251	xuexiang.shao@tsbiochem.com	China	29119	58

76155-56-1()Verwandte Suche:

---

• NSC 268710
• 10-[(3-AMino-2,36,-trideoxy-α-L-arabino-hexopyranosyl)oxy]-8-[(1S)-1,2 -dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-(8S,10S)-5,12-naphthacenedione Citrate
• 13-DihydroadriaMycin Citrate
• Epirubicinol (Mixture of DiastereoMers)
• 10-[(3-AMino-2,36,-trideoxy-α-L-arabino-hexopyranosyl)oxy]-8-[(1S)-1,2 -dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-(8S,10S)-5,12-naphthacenedione Hydrochloride
• 13-DihydroadriaMycin Hydrochloride
• 10-[(3-Amino-2,36,-trideoxy- -L-arabino-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-(8S,10S)-5,12-naphthacenedione
• Epidoxorubicino
• 13-dihydro-4'-epidoxorubicin
• Epidoxorubicinol
• (8S)-10α-[(3-Amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-8-[(S)-1,2-dihydroxyethyl]-6,8α,11-trihydroxy-7,8,9,10-tetrahydro-1-methoxy-5,12-naphthacenedione
• 4'-epi-Doxorubicinol
• Epirubicinol, 60% (Contains Unknown Salts) (Mixture of DiastereoMers)
• 4'-EpiadriaMycinol
• NSC 268238
• Epirubicinol, 60% (Contains Unknown Salts)
• 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
• Cariprazine Impurity 37
• (8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-((S)-1,2-dihydroxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
• 76155-56-1
• Inhibitor
• Intermediates & Fine Chemicals
• Pharmaceuticals
• Various Metabolites and Impurities
• Metabolites & Impurities